About NTx

Meet the team and learn about our mission.

Our Mission

To give therapy-resistant cancer patients an effective treatment option.

Experts in radiotheranostics

Based in the United Kingdom with global expertise, NuclideTx brings together science, technology, and translational leadership to advance the next generation of precision radiopharmaceuticals, turning molecular insight into powerful, life-changing therapies.

Team photo

Experts in radiotheranostics

Based in the United Kingdom with global expertise, NuclideTx brings together science, technology, and translational leadership to advance the next generation of precision radiopharmaceuticals, turning molecular insight into powerful, life-changing therapies.

Team photo

Our team

Experienced professionals dedicated to radiopharmaceutical innovation.

Portrait of Muhammet Tanç, Co-Founder and CEO

Co Founder & CEO

Muhammet Tanç, PhD

Portrait of Tim Witney, Co-Founder and CSO

Co Founder & CSO

Tim Witney, PhD

Portrait of Sofia Santos, Co-Founder and COO

Co Founder & COO

Sofia Santos, PhD

Portrait of Richard Edwards, Co-Founder and CTO

Co Founder & CTO

Richard Edwards, PhD

Portrait of Matthias Untisz, CFO

CFO

Matthias Untisz

Portrait of Andreas Kluge, Advisory Board Member

Advisory Board Member

Andreas Kluge, MD PhD

Portrait of Leigh Brody, Advisory Board Member

Advisory Board Member

Leigh Brody, PhD

Our investors

Logo

Grant funding

Wellcome logo

Strategic partners

Strategic partners

Kings College London logo
ABX-CRO logo
UCM Utrecht logo
Witney Lab logo

Connect with us

Email us, and keep updated on our clinical trial pipeline on LinkedIn.

Connect with us

Email us, and keep updated on our clinical trial pipeline on LinkedIn.